Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

References for PMC Articles for PubMed (Select 15604149)

1.

Molecular pathways of neurodegeneration in Parkinson's disease.

Dawson TM, Dawson VL.

Science. 2003 Oct 31;302(5646):819-22. Review.

PMID:
14593166
2.

Parkinson's disease: mechanisms and models.

Dauer W, Przedborski S.

Neuron. 2003 Sep 11;39(6):889-909. Review.

PMID:
12971891
3.

GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults.

Hanbury R, Ling ZD, Wuu J, Kordower JH.

J Comp Neurol. 2003 Jun 30;461(3):307-16.

PMID:
12746870
4.

Dietary restriction does not protect the nigrostriatal dopaminergic pathway of older animals from low-dose MPTP-induced neurotoxicity.

Morgan WW, Richardson AG, Nelson JF.

J Gerontol A Biol Sci Med Sci. 2003 May;58(5):B394-9.

PMID:
12730246
5.

Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.

Ai Y, Markesbery W, Zhang Z, Grondin R, Elseberry D, Gerhardt GA, Gash DM.

J Comp Neurol. 2003 Jun 23;461(2):250-61.

PMID:
12724841
6.

Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF.

Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ.

J Neurochem. 2003 Apr;85(2):299-305.

PMID:
12675906
7.

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.

Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P.

Nat Med. 2003 May;9(5):589-95. Epub 2003 Mar 31.

PMID:
12669033
8.

Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.

Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP.

Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2911-6. Epub 2003 Feb 14.

9.

Calorie restriction in rhesus monkeys.

Mattison JA, Lane MA, Roth GS, Ingram DK.

Exp Gerontol. 2003 Jan-Feb;38(1-2):35-46.

PMID:
12543259
10.

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, Laws ER Jr, Lozano AM, Penn RD, Simpson RK Jr, Stacy M, Wooten GF; ICV GDNF Study Group. Implanted intracerebroventricular. Glial cell line-derived neurotrophic factor.

Neurology. 2003 Jan 14;60(1):69-73.

PMID:
12525720
11.

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.

Lotharius J, Brundin P.

Nat Rev Neurosci. 2002 Dec;3(12):932-42. Review. No abstract available.

PMID:
12461550
12.

Recent developments in the pathology of Parkinson's disease.

Jellinger KA.

J Neural Transm Suppl. 2002;(62):347-76. Review.

PMID:
12456078
14.

Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys.

Grondin R, Zhang Z, Yi A, Cass WA, Maswood N, Andersen AH, Elsberry DD, Klein MC, Gerhardt GA, Gash DM.

Brain. 2002 Oct;125(Pt 10):2191-201.

15.

Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy.

Cabello CR, Thune JJ, Pakkenberg H, Pakkenberg B.

Neuropathol Appl Neurobiol. 2002 Aug;28(4):283-91.

PMID:
12175340
16.

Exercise: a behavioral intervention to enhance brain health and plasticity.

Cotman CW, Berchtold NC.

Trends Neurosci. 2002 Jun;25(6):295-301. Review.

PMID:
12086747
17.

Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration.

Palfi S, Leventhal L, Chu Y, Ma SY, Emborg M, Bakay R, Déglon N, Hantraye P, Aebischer P, Kordower JH.

J Neurosci. 2002 Jun 15;22(12):4942-54.

18.

Endogenous oxidative stress: relationship to aging, longevity and caloric restriction.

Barja G.

Ageing Res Rev. 2002 Jun;1(3):397-411. Review.

PMID:
12067594
19.

Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members.

Gratacòs E, Pérez-Navarro E, Tolosa E, Arenas E, Alberch J.

J Neurochem. 2001 Sep;78(6):1287-96.

PMID:
11579137
20.

Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine.

Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T.

J Neurosci. 2001 Jun 15;21(12):4427-35.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk